Drugs / SDJ001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06080984 | Oct 2023 → Oct 2024 | cancer | West China Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SDJ001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06080984 ↗ |
| Modality | Other / unclassified | “novel oncolytic virus SDJ001” NCT06080984 ↗ |
| Route | Other | “intratumoral treatment” NCT06080984 ↗ |